Skip to main content

GOLDMAN SACHS GROUP INC

Position in OTLK — Outlook Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in OTLK

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,116
-$70,219 QoQ
Shares Held
10,275
-77.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OTLK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in OTLK

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,116 10,275
2025-12-31 $72,335 45,782
2025-09-30 $45,548 42,970
2025-06-30 $147,788 92,368
2025-03-31 $126,298 103,524
2024-12-31 $112,380 59,461
2024-09-30 $189,965 35,574
2023-12-31 $21,800 55,334
2023-09-30 $13,532 61,232
2023-06-30 $230,759 132,621
2023-03-31 $77,413 71,022
2022-12-31 $202,550 187,547
2022-09-30 $115,513 94,684
2022-06-30 $107,363 105,259
2022-03-31 $245,854 138,121
2021-12-31 $151,400 111,324
2021-09-30 $327,908 151,110
2021-06-30 $26,356 10,585
2021-03-31 $194,125 86,278
2020-12-31 $59,568 45,822
2020-09-30 $55,673 77,324